Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease

Journal of Virology

Volumn 79, Issue 2, 2005, Pages 1036-1044

  De Groot Mijnes, Jolanda D F ^a,b   Van Dun, Jessica M ^a   Van Der Most, Robbert G ^a   De Groot, Raoul J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; VIRUS RNA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CAT DISEASE; CELLULAR IMMUNITY; CORONAVIRUS; DISEASE COURSE; DRUG SCREENING; EXPERIMENTAL MODEL; FATALITY; FEVER; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOBIOLOGY; IMMUNOPATHOLOGY; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALS; CATS; CD8-POSITIVE T-LYMPHOCYTES; CORONAVIRUS, FELINE; FELINE INFECTIOUS PERITONITIS; IMMUNITY, CELLULAR; LYMPHOPENIA; VIRUS REPLICATION; WEIGHT LOSS;

EID: 11144226294     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.2.1036-1044.2005     Document Type: Article

References (57)

1. Benlhassan-Chahour, K., C. Penit, V. Dioszeghy, F. Vasseur, G. Janvier, Y. Riviere, N. Dereuddre-Bosquet, D. Dormont, R. Le Grand, and B. Vaslin. 2003. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIV-mac251: preliminary report of the effect of early antiviral therapy. J. Virol. 77:12479-12493.
2. Berger, A., C. Drosten, H. W. Doerr, M. Sturmer, and W. Preiser. 2004. Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection. J. Clin. Virol. 29:13-22.
3. Bergmann, C. C., J. D. Altman, D. Hinton, and S. A. Stohlman. 1999. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J. Immunol. 163:3379-3387.
4. Booth, C. M., L. M. Matukas, G. A. Tomlinson, A. R. Rachlis, D. B. Rose, H. A. Dwosh, S. L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I. E. Ephtimios, I. Kitai, B. D. Mederski, S. B. Shadowitz, W. L. Gold, L. A. Hawryluck, E. Rea, J. S. Chenkin, D. W. Cescon, S. M. Poutanen, and A. S. Detsky. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289:2801-2809.
5. Brown, T. D. K., and I. Brierly. 1995. The coronaviral nonstructural proteins, p. 191-217. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
6. Chakrabarti, S., K. Brechung, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
7. Corapi, W. V., C. W. Olsen, and F. W. Scott. 1992. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol. 66:6695-6705.
8. Cui, W., Y. Fan, W. Wu, F. Zhang, J. Y. Wang, and A. P. Ni. 2003. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin. Infect. Dis. 37:857-859.
9. de Groot, R. J., and M. C. Horzinek. 1995. Feline infectious peritonitis, p. 239-309. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
10. de Groot-Mijnes, J. D. F., R. G. van der Most, J. M. van Dun, E. G. te Lintelo, N. M. P. Schuurman, H. F. Egberink, and R. J. de Groot. 2004. Three-color flow cytometry detection of virus-specific CD4+ and CD8+ T cells in the cat. J. Immunol. Methods 285:41-54.
11. de Vries, A. A. F., M. C. Horzinek, P. J. M. Rottier, and R. J. de Groot. 1997. The genome organization of the nidovirales: similarities and differences between arteri-, toro-, and coronaviruses. Semin. Virol. 8:33-47.
12. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J. C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H. D. Klenk, A. D. Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
13. Earl, P. L., A. W. Hugin, and B. Moss. 1990. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J. Virol. 64:2448-2451.
14. Fouchier, R. A., N. G. Hartwig, T. M. Bestebroer, B. Niemeyer, J. C. De Jong, J. H. Simon, and A. D. Osterhaus. 2004. A previously undescribed corona-virus associated with respiratory disease in humans. Proc. Natl. Acad. Sci. USA 101:6212-6216.
15. Gut, M., C. M. Leutenegger, J. B. Huder, N. C. Pedersen, and H. Lutz. 1999. One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J. Virol. Methods 77:37-46.
16. Haagmans, B. L., H. F. Egberink, and M. C. Horzinek. 1996. Apoptosis and T-cell depletion during feline infectious peritonitis. J. Virol. 70:8977-8983.
17. Haijema, B. J., H. Volders, and P. J. M. Rottier. 2004. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J. Virol. 78:3863-3871.
18. Hayashi, T., N. Sasaki, Y. Ami, and K. Fujiwara. 1983. Role of thymus-dependent lymphocytes and antibodies in feline infectious peritonitis after oral infection. Nippon Juigaku Zasshi 45:759-766.
19. Herrewegh, A. A., H. Vennema, M. C. Horzinek, P. J. Rottier, and R. J. de Groot. 1995. The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 212:622-631.
20. Hohdatsu, T., M. Nakamura, Y. Ishizuka, H. Yamada, and H. Koyama. 1991. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Ajrch. Virol. 120:207-217.
21. Hunziker, L., M. Recher, A. J. Macpherson, A. Ciurea, S. Freigang, H. Hengartner, and R. M. Zinkernagel. 2003. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4:343-349.
22. Kipar, A., K. Kohler, W. Leukert, and M. Reinacher. 2001. A comparison of lymphatic tissues from cats with spontaneous feline infectious peritonitis (FIP), cats with FIP virus infection but no FIP, and cats with no infection. J. Comp. Pathol. 125:182-191.
23. Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E. Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, and L. J. Andersen. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966.
24. Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G. M. Joynt, A. Ahuja, M. Y. Yung, C. B. Leung, K. F. To, S. F. Lui, C. C. Szeto, S. Chung, and J. J. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:1986-1994.
25. Leung, W. K., K. To, P. K. S. Chan, H. L. Y. Chan, A. K. L. Wu, N. Lee, K. Y. Yuen, and J. J. Y. Sung. 2003. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125:1011-1017.
26. McKeirnan, A. J., J. F. Evermann, A. Hargis, and R. L. Ott. 1981. Isolation of feline coronaviruses from two cats with diverse disease manifestations. Feline Pract. 11:17-20.
27. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
28. O'Brien, S. J., M. E. Roelke, L. Marker, A. Newman, C. A. Winkler, D. Meltzer, L. Colly, J. F. Evermann, M. Bush, and D. E. Wildt. 1985. Genetic basis for species vulnerability in the cheetah. Science 227:1428-1434.
29. Okada, H., F. Kobune, T. A. Sato, T. Kohama, Y. Takeuchi, T. Abe, N. Takayama, T. Tsuchiya, and M. Tashiro. 2000. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch. Virol. 145:905-920.
30. Paltrinieri, S, M. P. Cammarata, G. Cammarata, and S. Comazzi. 1998. Some aspects of humoral and cellular immunity in naturally occuring feline infectious peritonitis. Vet. Immunol. Immunopathol. 65:205-220.
31. Palucka, K., and J. Banchereau. 2002. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr. Opin. Immunol. 14:420-431.
32. Pedersen, N. C., and J. F. Boyle. 1980. Immunological phenomena in the effusive form of feline infectious peritonitis. Am. J. Vet. Res. 41:868-876.
33. Pedersen, N. C., J. F. Evermann, A. J. McKeirnan, and R. L. Ott. 1984. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am. J. Vet. Res. 45:2580-2585.
34. Pedersen, N. C., and K. Floyd. 1985. Experimental studies with three new strains of feline infectious peritonitis virus: FIPV-UCD2, FIPV-UCD3 and FIPV-UCD4. Compend. Contin. Educ. Pract. Vet. 7:1001-1011.
35. Peiris, J. S., S. T. Lai, L. L. Poon, Y. Guan, L. Y. Yam, W. Lim, J. Nicholls, W. K. Yee, W. W. Yan, M. T. Cheung, V. C. Cheng, K. H. Chan, D. N. Tsang, R. W. Yung, T. K. Ng, and K. Y. Yuen. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325.
36. Poland, A. M., H. Vennema, J. E. Foley, and N. C. Pedersen. 1996. Two related strains of feline infectious peritonitis virus isolated from immuno-compromised cats infected with a feline enteric coronavirus. J. Clin. Microbiol. 34:3180-3184.
37. Poutanen, S. M., D. E. Low, B. Henry, S. Finkelstein, D. Rose, K. Green, R Tellier, R. Draker, D. Adachi, M. Ayers, A. K, Chan, D. M. Skowronski, I. Salit, A. E. Simor, A. S. Slutsky, P. W. Doyle, M. Krajden, M. Petric, R. C. Brunham, and A. J. McGeer. 2003. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348:1995-2005.
38. Reed, L. H., and H. Münch. 1938. A simple method for estimating 50 percent endpoints. Am. J. Hyg. 27:493-497.
39. Schneider-Schaulies, S., K, Bieback, E. Avota, I. Klagge, and V. ter Meulen. 2002. Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation. J. Mol. Med. 80:73-85.
40. Servet-Delprat, C., P. O. Vidalain, H. Valentin, and C. Rabourdin-Combe. 2003. Measles virus and dendritic cell functions: how specific response co-habits with immunosuppression. Curr. Top. Microbiol. Immunol. 276:103-123.
41. Stoddart, C. A., and F. W. Scott. 1988. Isolation and identification of feline peritoneal macrophages for in vitro studies of coronavirus-macrophage interactions. J. Leukoc. Biol. 44:319-328.
42. Stoddart, M. E., J. T. Whicher, and D. A. Harbour. 1988. Cats inoculated with feline infectious peritonitis virus exhibit a biphasic acute phase plasma protein response. Vet. Rec. 123:622-624.
43. Summers, K. L., B. D. Hock, J. L. McKenzie, and D. N. Hart. 2001. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 159:285-295.
44. Tresnan, D. B., R. Levis, and K. V. Holmes. 1996. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J. Virol. 70:8669-8674.
45. Tsang, O. T., T. N. Chau, K. W. Choi, E. Y. K. Tso, W. Lim, M. C. Chiu, W. L. Tong, P. O. Lee, B. H. S. Lam, T. K. Ng, J. Y. Lai, W. C. Yu, and S. T. Lai. 2003. Severe acute respiratory syndrome: recurrence? Hospital infection? Emerg. Infect. Dis. 9:1180-1181.
46. van der Hoek, L., K. Pyrc, M. F. Jebbink, W. Verraeulen-Oost, R. J. M. Berkhout, K. C. Wolthers, P. M. E. Wertheim-van Dillen, J. Kaandorp, J. Spaargaren, and B. Berkhout. 2004. Indentification of a new human coronavirus. Nat. Med. 10:368-373.
47. van der Most, R. G., K. Murali-Krishna, J. G. Lanier, E. J. Wherry, M. T. Puglielli, J. N. Blattman, A. Sette, and R. Ahmed. 2003. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 315:93-102.
48. Vennema, H., R. J. de Groot, D. A. Harbour, M. Dalderup, T. Gruffydd-Jones, M. C. Horzinek, and W. J. Spaan. 1990. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 64:1407-1409.
49. Vennema, H., R. J. de Groot, D. A. Harbour, M. C. Horzinek, and W. J. Spaan. 1991. Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology 181:327-335.
50. Vennema, H., A. Poland, J. Foley, and N. C. Pedersen. 1998. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 243:150-157.
51. Ward, J. M., D. H. Gribble, and D. L. Dungworth. 1974. Feline infectious peritonitis: experimental evidence for its multiphasic nature. Am. J. Vet. Res. 35:1271-1275.
52. Weiss, R. C., and N. R. Cox. 1989. Evaluation of immunity to feline infectious peritonitis in cats with cutaneous viral-induced delayed hypersensitivity. Vet. Immunol. Immunopathol. 21:293-309.
53. Weiss, R. C., and F. W. Scott. 1981. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 4:175-189.
54. Weiss, R. C., and F. W. Scott. 1981. Pathogenesis of feline infectious peritonitis: nature and development of viremia. Am. J. Vet. Res. 42:382-390.
55. Weiss, R. C., and F. W. Scott. 1981. Pathogenesis of feline infectious peritonitis: pathologic changes and immunofluorescence. Am. J. Vet. Res. 42:2036-2048.
56. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-927.
57. Wong, R. S., A. Wu, K. F. To, N. Lee, C. W. Lam, C. K. Wong, P. K. Chan, M. H. Ng, L. M. Yu, D. S. Hui, J. S. Tam, G. Cheng, and J. J. Sung. 2003. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326:1358-1362.